Image

Breast Cancer Resiliency Through Exercise Program (B-REP)

Breast Cancer Resiliency Through Exercise Program (B-REP)

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and a health education control among 60 Black breast cancer survivors.

Eligibility

Inclusion Criteria:

Women will be eligible if they meet the following criteria:

  • self-identify as Black or African American or Afro-Latina/e;
  • are ≥18 years old;
  • have a confirmed diagnosis of breast cancer, Stage I to IIIA;
  • have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable;
  • are not meeting current cancer-specific resistance exercise guidelines of ≥ 2 times per week; and
  • are able to speak and understand English.

Exclusion Criteria:

  • metastatic disease;
  • medical reason that precludes them from increasing current exercise levels;
  • planned elective surgery during study period;
  • pregnant or plans to become pregnant during the study period;
  • plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States);
  • current enrollment in another exercise trial; and/or
  • inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.

Study details
    Breast Cancer Female

NCT06100263

University of Michigan Rogel Cancer Center

15 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.